Thumbnail Image
Publication

Erectile dysfunction and ischaemic heart disease

Date
2018
Abstract
Erectile dysfunction (ED) is a common disorder that affects the quality of life of many patients. It is prevalent in more than half of males aged over 60 years. Increasing evidence suggests that ED is predominantly a vascular disorder. Endothelial dysfunction seems to be the common pathological process causing ED. Many common risk factors for atherosclerosis such as diabetes, hypertension, smoking, obesity and hyperlipidaemia are prevalent in patients with ED and so management of these common cardiovascular risk factors can potentially prevent ED. Phosphodiesterase type 5 inhibitors provide short-term change of haemodynamic factors to help initiate and maintain penile erection. They have been shown to be an effective and safe treatment strategy for ED in patients with heart disease, including those with ischaemic heart disease and hypertension.
Supervisor
Description
peer-reviewed
Publisher
Radcliffe Cardiology
Citation
European Cardiology Review;13, pp. 98-103
Collections
School of Medicine
Show all metadata
Files
Thumbnail Image
Stack_2018_Erectile.pdf
Adobe PDF, 660.52 KB
Keywords
atherosclerosis, endothelial dysfunction, erectile dysfunction, ischaemic heart disease, phosphodiesterase inhibitors
ULRR Identifiers
https://researchrepository.ul.ie/handle/10344/8185
 https://doi.org/10.34961/6622
Funding code
Funding Information
Sustainable Development Goals
External Link
Type
Article
Rights
https://creativecommons.org/licenses/by-nc-sa/1.0/
License